1.33BMarket Cap-2.46P/E (TTM)
10.010High9.580Low862.83KVolume9.580Open9.580Pre Close8.37MTurnover0.93%Turnover RatioLossP/E (Static)137.72MShares14.45052wk High1.07P/B895.02MFloat Cap6.56052wk Low--Dividend TTM92.75MShs Float141.010Historical High--Div YieldTTM4.49%Amplitude6.560Historical Low9.697Avg Price1Lot Size
Vir Biotechnology Stock Forum
They don't simply give such a high price target for nothing.
$Vir Biotechnology (VIR.US)$
Congratulations to trader who have bought it on premarket for day trade profit.
Market is going downtrend for the incoming fed announcement. Lock on profit today as tomorrow market will be closed.
Today good opportunity to swing trade $ $Sana Biotechnology (SANA.US)$ $Absci Corp (ABSI.US)$
Pick the right momentum stock to trade for profit.
Follow me, follow momentum
Vir Biotechnology Is Presenting Initial Phase 1 Data From Two Of Its Dual-masked T-cell Engagers (TCEs): VIR-5818, Targeting A Variety Of HER2-expressing Solid Tumors; And VIR-5500, Targeting PSMA In Metastatic Castration-resistant Prostate Cancer
Vir Biotechnology Inc - Vir-5818 Shows 50% Tumor Shrinkage in Her2 Cancers at ≥400 ΜG/Kg
No comment yet